Anna Witkowska

Summary

Affiliation: Institute of Oncology
Country: Poland

Publications

  1. ncbi Overrepresentation of the short arm of chromosome 12 in seminoma and nonseminoma groups of testicular germ cell tumors
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, 5 K W Roentgen Str, 02 781, Warsaw, Poland
    Cancer Genet Cytogenet 134:102-8. 2002
  2. ncbi Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, The Memorial M Sklodowska Curie Cancer Centre and Institute, Roentgen Str 5, 02 781 Warsaw, Poland
    Cancer Genet Cytogenet 156:114-21. 2005
  3. ncbi Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript
    Barbara Pienkowska-Grela
    Maria Skladowska Curie Memorial Cancer Centre and Institute, K W Roentgen Str 5, 02 781Warsaw, Poland
    Cancer Genet Cytogenet 174:111-5. 2007
  4. ncbi Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib
    Barbara Pienkowska-Grela
    Cytogenetics Laboratory, The Marie Sklodowska Curie Institute of Oncology, Warsaw, Poland
    Leuk Lymphoma 50:952-65. 2009
  5. ncbi Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, Department of Lymphoprolipherative Disease, MSCM Cancer Centre and Institute, 5 W K Roentgen Str, 02 781, Warsaw, Poland
    Med Oncol 28:1589-95. 2011
  6. ncbi Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL)
    Renata Woroniecka
    Centre of Oncology, M Skłodowska Curie Memorial Institute, Cytogenetic Department, ul Roentgena 5, 02 781 Warszawa, Poland
    J Appl Genet 43:545-53. 2002

Collaborators

  • Renata Woroniecka
  • Beata Grygalewicz
  • Grzegorz Rymkiewicz
  • Barbara Pienkowska-Grela
  • Paulina Krawczyk
  • Anna Pastwińska
  • Lech Konopka
  • Jan Walewski
  • Jolanta Rygier
  • Katarzyna Czyz-Domanska
  • Bernadeta Ceglerek
  • Ilona Seferynska
  • Anna Sikorska
  • Miroslaw Majewski
  • Kinga Kos
  • Iwona Solarska
  • Urszula Bregula

Detail Information

Publications6

  1. ncbi Overrepresentation of the short arm of chromosome 12 in seminoma and nonseminoma groups of testicular germ cell tumors
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, 5 K W Roentgen Str, 02 781, Warsaw, Poland
    Cancer Genet Cytogenet 134:102-8. 2002
    ..Heterogeneity in the copy number of i(12p) and other 12p-derived markers, as well as chromosome 12 aneuploidy, were higher in NS tumors than in SE...
  2. ncbi Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, The Memorial M Sklodowska Curie Cancer Centre and Institute, Roentgen Str 5, 02 781 Warsaw, Poland
    Cancer Genet Cytogenet 156:114-21. 2005
    ..This study indicates that the mechanisms of C-MYC activation involved in BLL can be different from that for the BL...
  3. ncbi Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript
    Barbara Pienkowska-Grela
    Maria Skladowska Curie Memorial Cancer Centre and Institute, K W Roentgen Str 5, 02 781Warsaw, Poland
    Cancer Genet Cytogenet 174:111-5. 2007
    ..Our data seem to confirm the data of others in regards to the b2a3 breakpoint, suggesting a better prognosis, regardless of other unfavorable factors...
  4. ncbi Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib
    Barbara Pienkowska-Grela
    Cytogenetics Laboratory, The Marie Sklodowska Curie Institute of Oncology, Warsaw, Poland
    Leuk Lymphoma 50:952-65. 2009
    ..The risk of progression of cytogenetic changes in group with deletion was more than nine times higher than in patients with sole t(9;22) without deletion (statistically significant)...
  5. ncbi Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement
    Barbara Pienkowska-Grela
    Cytogenetic Laboratory, Department of Lymphoprolipherative Disease, MSCM Cancer Centre and Institute, 5 W K Roentgen Str, 02 781, Warsaw, Poland
    Med Oncol 28:1589-95. 2011
    ..Identifying such an aberration may be helpful in the diagnostics of Inter-DLBCL/BL eventually forming a distinct subgroup of lymphomas...
  6. ncbi Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL)
    Renata Woroniecka
    Centre of Oncology, M Skłodowska Curie Memorial Institute, Cytogenetic Department, ul Roentgena 5, 02 781 Warszawa, Poland
    J Appl Genet 43:545-53. 2002
    ..In this study we show that detection of chromosomal abnormalities is useful in diagnosis of MCL and has some prognostic significance...